Business Times article: How Singapore can lead Biopharma Innovation by Interpat & SAPI

Interpat supported SAPI (Singapore Association of Pharmaceutical Industries) and contributed to this article which highlights the importance of safeguarding Singapore’s attractiveness as a biopharmaceutical innovation hub through strong IP protection.